Feedback Form

Product Name 

Aryl hydrocarbon Receptor antibody [RPT1]

 

See all Aryl hydrocarbon Receptor antibodies (7)...

Product type 

Primary antibodies

Description 

Mouse monoclonal [RPT1] to Aryl hydrocarbon Receptor

Immunogen 

Synthetic Peptide: (12)RKRRKP (17)V(22)K PIPAEGIK(3
Immunizing peptide corresponds to amino acid residues 12-31 from the mouse AhR protein with amino acids 18-21 being omitted.

Reacts with 
(species key)

Hu, Ms, Rat

Specificity 

Detects the aryl hydrocarbon receptor (AhR).

Tested applications 
(see key)

IHC-P, IP, WB


Abreviews 

Customer reviews
(see key)


Read about Abreviews
(Read all Abreviews)

Submit an Abreview and earn up to 220 Abpoints by reviewing this product

• WB

3 Abreviews

- average rating: 4 stars (out of 5)4 stars (out of 5)4 stars (out of 5)4 stars (out of 5)4 stars (out of 5)


WB
(read Abreview)


Application notes 
(see key)

Recommended dilutions
IHC-P: Use at an assay dependent dilution (PMID 19617203).
IP: Use at an assay dependent dilution. Although ab2770 can be used in immunoprecipitation procedures, clone RPT9 is recommended for this procedure.
WB: 1/1000. Detects a band of approximately 95 kDa (predicted molecular weight: 94 kDa).


Not yet tested in other applications.
Optimal dilutions/concentrations should be determined by the end user.

Cellular localization 

First cytoplasmic, upon binding with ligand and interaction with a HSP90, it translocates to the nucleus.

Research areas 

Chromatin and Nuclear Signaling >> Transcription >> Domain Families >> HLH / Leucine Zipper >> Helix-Turn-Helix

Relevance 

The Aryl Hydrocarbon Receptor (AHR), also known as the dioxin receptor, is a ligand-activated helix/loop/helix transcription factor found in a variety of vertebrate species. The known ligands for AHR are foreign planar aromatic compounds, such as polycyclic aromatic compounds and halogenated aromatic compounds such as 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).

Unlike the steroid/thyroid hormone receptors, there is no known physiological ligand for the AH Receptor. Studies indicate that in non-ligand activated cells, AHR is found complexed with HSP90 predominantly in the cytoplasm. Upon binding to an agonist, the ligand-activated AHR is believed to transform to a nuclear, DNA binding form. This transformation process appears to involve dissociation of HSP90 from AHR followed by formation of a heterodimer with AHR nuclear translocator protein (Arnt). The AHR-ligand complex appears to initiate gene transcription of cytochrome P450 1A1.

 

Alternative names Aryl hydrocarbon Receptor antibody [RPT1] (ab2770)

Database links 

The links below go to external sites and will open in a new browser window

Entrez Gene

    

196    (Human)
11622    (Mouse)
25690    (Rat)

Omim

    

600253    (Human)

SwissProt

    

P35869    (Human)
P30561    (Mouse)
P41738    (Rat)

Unigene

    

171189    (Human)
91370    (Rat)

Raised in 

Mouse

Clonality 

Monoclonal

Clone number 

RPT1

Isotype 

IgG1

Purity 

Ascites

Storage buffer 

Ascitic fluid with 0.05% sodium azide

Material safety datasheet (MSDS) for this product:
Sodium Azide MSDS

Form 

Liquid

Concentration 

Concentration not determined - why is this?

Storage instructions 

Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.

 

At Abcam, we have one centralized database to hold all of our product information, so that everything we know about this Aryl hydrocarbon Receptor antibody [RPT1] is on this datasheet. But please do contact us if you would like any reassurance!



References for Aryl hydrocarbon Receptor antibody [RPT1] (ab2770)

Specific publication references   This product has been used in: (two most recent references)

Khuda-Bukhsh AR et al. Modulation of Signal Proteins: A Plausible Mechanism to Explain How a Potentized Drug Secale Cor 30C Diluted beyond Avogadro's Limit Combats Skin Papilloma in Mice. Evid Based Complement Alternat Med : (2009). IHC-P; Mouse. PubMed: 19617203

Gramatzki D et al. Aryl hydrocarbon receptor inhibition downregulates the TGF-beta/Smad pathway in human glioblastoma cells. Oncogene 28:2593-605 (2009). WB. PubMed: 19465936


See all 5 publication references for this product.


If you publish research using ab2770 please let us know so that we can cite the reference on this datasheet.

 

Search PubMed (MEDLINE) for references to Aryl hydrocarbon Receptor

 

Aryl hydrocarbon Receptor antibody [RPT1] - more information

Customer reviews (feedback) regarding Aryl hydrocarbon Receptor antibody [RPT1]

Customer FAQs regarding Aryl hydrocarbon Receptor antibody [RPT1]

Protocols for Aryl hydrocarbon Receptor antibody [RPT1]

Price and availability of products related to Aryl hydrocarbon Receptor antibody [RPT1]

 

Aryl hydrocarbon Receptor antibody [RPT1] - related products:

Products for Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)

Slides

Products for Western blot

Loading controls

Lysates

 

Compatible Secondaries for Aryl hydrocarbon Receptor antibody [RPT1]

ab2891

  

HRP polymer antibody

ab6563

  

Cy5 ® antibody

ab6726

  

Texas Red ® antibody

ab6728

  

HRP antibody

ab6729

  

Alkaline Phosphatase antibody

ab6785

  

FITC antibody

ab6788

  

Biotin antibody

ab7002

  

Phycoerythrin antibody

ab7018

  

Agarose antibody

ab27229

  

15nm Gold antibody

ab27230

  

10nm Gold antibody

ab27231

  

15nm Gold antibody

ab27233

  

5nm Gold antibody

ab27241

  

10nm Gold antibody

ab27242

  

20nm Gold antibody

ab27243

  

40nm Gold antibody

ab27244

  

5nm Gold antibody

ab60313

  

Chromeo™ 488 antibody

ab60316

  

Chromeo™ 546 antibody

ab60318

  

Chromeo™ 642 antibody

 

Other Aryl hydrocarbon Receptor Antibodies

See all Aryl hydrocarbon Receptor antibodies (7)...

 

Aryl hydrocarbon Receptor antibody [RPT1] - other tools:

Contact Abcam with a Technical Enquiry about Aryl hydrocarbon Receptor antibody [RPT1]

 

All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

©1998-2010 Abcam plc. All rights reserved.